Clinical Trial Detail

NCT ID NCT04253262
Title A Study of Copanlisib Combined With Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Brown University
Indications

prostate cancer

Therapies

Copanlisib + Rucaparib

Age Groups: adult senior

Additional content available in CKB BOOST